Get a weekly digest of the latest psychedelic research, new studies, and platform updates delivered to your inbox.
No spam, ever. Unsubscribe anytime.
A 29-year-old male with prior testicular cancer and daily ketamine use developed severe lower urinary tract symptoms due to bladder fibrosis. Despite multiple treatments - botulinum toxin type A , bladder distension, and medications - his condition progressed to hydronephrosis, recurrent urosepsis, and acute kidney injury requiring nephrostomies. Eventually, a Bricker bladder was created. The case highlights ketamine-associated uropathy as an ongoing and underrecognized issue, stressing the importance of early cessation and targeted intervention.
Sign in to join the discussion.
Basic research